Funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
quoting
naddr1qv…mylwMiles Wang, an OpenAI researcher, is reportedly leaving to found a startup focused on AI for drug discovery. He is in discussions to raise approximately $200 million at a $2 billion valuation. The new venture may explore finding new uses for existing drugs, which could accelerate revenue generation. - OpenAI researcher Miles Wang is leaving to launch a new startup focused on AI for drug discovery. - Wang is reportedly in talks to raise about $200 million at a $2 billion valuation. - Several other OpenAI researchers are expected to join Wang's new company. - The startup may focus on AI models that find new uses for existing drugs or those that previously failed trials. - Investor interest in AI for life sciences is highlighted by other recent funding rounds in the sector. Continue reading https://techcrunch.com/2026/07/14/openai-researcher-miles-wang-in-talks-to-launch-ai-drug-discovery-startup-valued-at-2b/